138 related articles for article (PubMed ID: 4070320)
1. Diurnal lipid and lipoprotein profiles with bezafibrate and clofibrate in healthy volunteers.
Oster P; Schlierf G; Lang PD; Mordasini R; Vollmar J
Pharmatherapeutica; 1985; 4(5):267-77. PubMed ID: 4070320
[TBL] [Abstract][Full Text] [Related]
2. Diurnal lipid and lipoprotein profiles in hypertriglyceridemic patients with bezafibrate and clofibrate.
Oster P; Lang PD; Vollmar J; Schlierf G
Res Exp Med (Berl); 1986; 186(6):435-41. PubMed ID: 3823619
[TBL] [Abstract][Full Text] [Related]
3. [Comparative double-blind investigation of bezafibrate and clofibrate in patients with primary hyperlipoproteinaemia].
Lageder H
Wien Klin Wochenschr; 1980 Feb; 92(3):95-101. PubMed ID: 6985560
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
Arntz HR; Klemens UH; Vollmar LJ; Lang PD
Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
[TBL] [Abstract][Full Text] [Related]
5. Effects of clofibrate on plasma lipids and high-density lipoprotein levels in renal allograft recipients.
Bagdade JD; Shantharam VV; Sollek M; Albers JJ
Clin Nephrol; 1979 Aug; 12(2):83-6. PubMed ID: 230927
[TBL] [Abstract][Full Text] [Related]
6. Effect of bezafibrate on the high-density lipoprotein subfractions HDL2 and HDL3 in primary hyperlipoproteinemia type IV.
Schwandt P; Weisweiler P
Artery; 1980; 7(6):464-70. PubMed ID: 7236016
[TBL] [Abstract][Full Text] [Related]
7. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
[TBL] [Abstract][Full Text] [Related]
8. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
[TBL] [Abstract][Full Text] [Related]
9. Effect of bezafibrate on lipids, lipoproteins, apolipoproteins and platelet aggregation in hypertriglyceridemic patients.
Waysbort J; Schwartz S; Brunner D
Arzneimittelforschung; 1994 Nov; 44(11):1217-22. PubMed ID: 7893284
[TBL] [Abstract][Full Text] [Related]
10. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
11. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
[TBL] [Abstract][Full Text] [Related]
12. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
Nye ER; Sutherland WH; Temple Wa
N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
[TBL] [Abstract][Full Text] [Related]
13. Diurnal changes in plasma lipoproteins of free-living healthy men consuming a standard diet.
Fainaru M; Schafer Z; Gavish D; Skurnik Y; Argov R; Kaplan S
Isr J Med Sci; 1994 Jan; 30(1):83-9. PubMed ID: 8138399
[TBL] [Abstract][Full Text] [Related]
14. Effects of pea and soybean fibre on postprandial lipaemia and lipoproteins in healthy adults.
Dubois C; Cara L; Armand M; Borel P; Senft M; Portugal H; Pauli AM; Bernard PM; Lafont H; Lairon D
Eur J Clin Nutr; 1993 Jul; 47(7):508-20. PubMed ID: 8404786
[TBL] [Abstract][Full Text] [Related]
15. Improvement of hyperlipidaemia by bezafibrate treatment in RDT patients.
Grützmacher P; Scheuermann E; Lang W
Proc Eur Dial Transplant Assoc; 1981; 18():169-75. PubMed ID: 7036147
[TBL] [Abstract][Full Text] [Related]
16. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[TBL] [Abstract][Full Text] [Related]
17. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
Langsted A; Freiberg JJ; Nordestgaard BG
Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
[TBL] [Abstract][Full Text] [Related]
18. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
Noseda G; Fragiacomo C; Weidmann P; Bachmann C
Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
[TBL] [Abstract][Full Text] [Related]
19. Effect of prolonged fasting on plasma lipids, lipoproteins and apolipoprotein B in 12 physicians participating in a hunger strike: an observational study.
Fainaru M; Schafer Z
Isr Med Assoc J; 2000 Mar; 2(3):215-9. PubMed ID: 10774270
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hyperlipoproteinaemia in diabetic patients (author's transl)].
Bruneder H; Klein HJ
Dtsch Med Wochenschr; 1981 Dec; 106(49):1653-6. PubMed ID: 7308007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
